Spectacular failures to replicate key scientific findings have serious consequences for research funding.

Credit: Shutterstock

1. A website called the National Observer is an "online only" publication whose editor has been accused of political boosterism and using her publication to attack opponents of her family.

Dannon has just incurred the wrath of Amy Porterfield Levy (a terrible idea by any measure) for the company's ridiculous pandering to the "anti-GM" religion. But, she's even more pissed than usual, because the company is treating women like idiots. Guess who the real idiots are?

What happens when we die? This question is both existential and biological. While scientists cannot address the first, they certainly can address the second. What happens to your body after you die is not pretty. Alas, there is no such thing as death with dignity when the microbial Grim Reaper arrives.

Despite the common notion among Americans that Europe is a progressive, technologically advanced utopia, the reality is that the continent -- when it comes to matters of science -- is rather backward. Now, a very harsh report in the most recent issue of Trends in Biotechnology underscores the infuriating extent of the problem.

When is comes to drug discovery and development, the clock is always ticking. This clock affects both drug companies and patients. Pfizer's Dr. Robert Popovian explains.

Dallas Mavericks owner Mark Cuban suddenly has a lot to say about drug prices. Does he know what he's talking about? In return, we offer him advice on how to run his team.

Medicaid gets hundreds of billions of dollars in funding, and more coming with Obamacare. So why only spend $100 million preventing smoking?

What happens when a family leads a "plastic-free" life for two months? You may be surprised.